Log in to save to my catalogue

Uncovering the mode of action of engineered T cells in patient cancer organoids

Uncovering the mode of action of engineered T cells in patient cancer organoids

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9849137

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Extending the success of cellular immunotherapies against blood cancers to the realm of solid tumors will require improved in vitro models that reveal therapeutic modes of action at the molecular level. Here we describe a system, called BEHAV3D, developed to study the dynamic interactions of immune cells and patient cancer organoids by means of ima...

Alternative Titles

Full title

Uncovering the mode of action of engineered T cells in patient cancer organoids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9849137

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9849137

Other Identifiers

ISSN

1087-0156,1546-1696

E-ISSN

1546-1696

DOI

10.1038/s41587-022-01397-w

How to access this item